Moderna's experimental cancer vaccine treats but doesn't prevent melanoma – a biochemist explains how it works
- Written by Mark R. O'Brian, Professor and Chair of Biochemistry, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo

Mediaoutlets have reported the encouraging findings of clinical trials for a new experimental vaccine developed by the biotech company Moderna to treat an aggressive type of skin cancer called melanoma.
Although...